AT Fleischauer, PS Diaz, D Giles, DJ
Biosurveillance Coordination Unit, Centers for Disease Control and Prevention (CDC),
Background: Homeland Security Presidential Directive 21 (HSPD-21) mandates development of an integrated national biosurveillance capability to provide early warning and characterization of urgent events. CDC is leading the development of a nationwide human health biosurveillance strategy by engaging public and private stakeholders and all levels of government to plan for investments in scientifically-sound innovations. An assessment of the current biosurveillance capability is a pre-requisite to developing a well-informed strategy for the future of biosurveillance.
Results: Biosurveillance is the collection and integration of timely health-related information for public health action achieved through the early detection, characterization, and situation awareness of exposures and acute human health events of public health significance. The scope is all-hazards of public health significance, consistent with the International Health Regulations (2005). A biosurveillance capability is a function of information derived from both structured and unstructured surveillance and epidemiologic investigation, all of which are highly dependent on a skilled public health workforce. Biosurveillance information will be characterized by timeliness, representativeness, quality and usefulness, and sustainability to provide an estimate of current capability.